Sponsored
link_iid
Only one antibody treatment works against omicron — and it's running out
Pharmaceutical company GlaxoSmithKline announced that its sotrovimab monoclonal antibody “retains in vitro activity against th... View More
Only one antibody treatment works against omicron — and it's running out
Pharmaceutical company GlaxoSmithKline announced that its sotrovimab monoclonal antibody “retains in vitro activity against the full known omicron spike protein.”
Be the first person to like this.
People Also Like
TV Show
TV Show